Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

10 avr. 2026 17h02 HE | Source: Replimune, Inc.

Replimune Receives Complete Response Letter from the FDA for RP1 Biologics License Application for the Treatment of Advanced Melanoma

WOBURN, Mass., April 10, 2026 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today...
10 avr. 2026 14h27 HE | Source: Portnoy Law

Portnoy Law Firm Announces Class Action on Behalf of Atara Biotherapeutics, Inc. Investors

LOS ANGELES, April 10, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Atara Biotherapeutics, Inc., (“Atara” or the "Company") (NASDAQ: ATRA) investors of a class action on behalf of investors...
10 avr. 2026 14h00 HE | Source: MOVA AtomForm

MOVA AtomForm Unveils 12-Nozzle Multi-Color 3D Printing System at RAPID + TCT 2026

MOVA AtomForm debuts the Palette 300 at RAPID + TCT 2026, featuring a 12-nozzle system that eliminates waste and brings AI-driven efficiency to creators.
10 avr. 2026 13h53 HE | Source: Hagens Berman Sobol Shapiro LLP

INVESTOR DEADLINE: uniQure (QURE) Investors with Substantial Losses Have Opportunity to Lead the uniQure Class Action Lawsuit– Hagens Berman

Investors who lost money in QURE after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.